AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Join the community
Most Read
1. Innovative broadcasting companies spotlighted at Asia-Pacific Broadcasting+ Awards 2025 2. Solar and wind seen to energise 30% of ASEAN’s data centres in 2030 3. S-REITs shift to cash-backed yields, eye 5.5% in FY 2025 4. Asia’s insurance markets grow in 2024 on life, health gains 5. Medical cannabis market to hit $87.41b by 2030Resource Center
Awards
Sep
25
Sep
25
Event News
Co-Written / Partner
Cynosure® Lutronic® recognised at the SBR Technology Excellence Awards 2025 for Machine – Healthcare Technology
DermaV™, the latest vascular laser system from Cynosure® Lutronic®, offers an all-in-one solution for 55+ skin indications.
Commentary
Business partnership as TKDN services: Unlocking Indonesia’s digital future